TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32488672

Group type: EXPERIMENTAL
Intervention: Stage 1 or higher AKI
Number of subjects: 923

Group type: EXPERIMENTAL
Intervention: Severe AKI (stage 2 or higher)
Number of subjects: 923

Group type: EXPERIMENTAL
Intervention: AKI stage 1 or higher during early follow-up (days 3-7)
Number of subjects: 923

Group type: EXPERIMENTAL
Intervention: AKI stage 1 or higher during middle follow-up (days 8-14)
Number of subjects: 923

Group type: EXPERIMENTAL
Intervention: AKI stage 1 or higher during late follow-up (after day 14)
Number of subjects: 923

Group type: EXPERIMENTAL
Intervention: Severe AKI rates for 24-week GA group
Number of subjects: 923

Group type: EXPERIMENTAL
Intervention: Severe AKI rates for 25-week GA group
Number of subjects: 923

Group type: EXPERIMENTAL
Intervention: Severe AKI rates for 26-week GA group
Number of subjects: 923

Group type: EXPERIMENTAL
Intervention: Severe AKI rates for 27-week GA group
Number of subjects: 923
Study: 35543679

Group type: EXPERIMENTAL
Intervention: SherpaPak controlled cold organ system
Number of subjects: 81

Group type: COMPARATOR
Intervention: Conventional ice storage technique
Number of subjects: 81
Study: 32176882

Group type: EXPERIMENTAL
Intervention: Bovine milk fat globule membrane (MFGM) concentrates
Number of subjects: 0
Study: 35085016

Group type: EXPERIMENTAL
Intervention: Individualized homeopathic medicines (IHMs)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 32732787

Group type: EXPERIMENTAL
Intervention: Follow-up telephone call program (n=1534)
Number of subjects: 3054

Group type: COMPARATOR
Intervention: Usual care discharge (n=1520)
Number of subjects: 3054
Study: 36364960

Group type: EXPERIMENTAL
Intervention: Intervention group (1347 individuals)
Number of subjects: 2693

Group type: COMPARATOR
Intervention: Control group (1346 individuals)
Number of subjects: 2693
Study: 33861384

Group type: EXPERIMENTAL
Intervention: Exposure-based cognitive behavioral therapy (CBT) for OCD, 14 weekly sessions
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Children and adolescents with HA symptoms
Number of subjects: 269

Group type: COMPARATOR
Intervention: Children and adolescents without HA symptoms
Number of subjects: 269
Study: 34027716

Group type: EXPERIMENTAL
Intervention: 8-week behavioral physical activity intervention
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 32
Study: 32354152

Group type: EXPERIMENTAL
Intervention: 5 g PHGG up to three times per day for 3 weeks
Number of subjects: 20
Study: 34420375

Group type: EXPERIMENTAL
Intervention: Venlafaxine (1 mg/kg for 60 days)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 33432496

Group type: EXPERIMENTAL
Intervention: Plain bupivacaine
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Mixture of liposomal bupivacaine and plain bupivacaine
Number of subjects: 90
Study: 35183790

Group type: EXPERIMENTAL
Intervention: Image-guided adaptive radiotherapy combined with hepatic artery chemoembolization
Number of subjects: 84

Group type: COMPARATOR
Intervention: Hepatic artery chemoembolization
Number of subjects: 84
Study: 34851411

Group type: EXPERIMENTAL
Intervention: 20 mg per day intranasal OP0201 for 10 days
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study: 34426106

Group type: EXPERIMENTAL
Intervention: Adalimumab (40 mg, subcutaneous, once)
Number of subjects: 68
Study: 32131881

Group type: EXPERIMENTAL
Intervention: Nebulized iloprost for 5 days
Number of subjects: 150

Group type: COMPARATOR
Intervention: NaCl 0.9% for 5 days (Control)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Nebulized iloprost
Number of subjects: 150
Study: 35773028

Group type: EXPERIMENTAL
Intervention: Distal nerve blocks (IPACK, triangle femoral and obturator nerve blocks)
Number of subjects: 90
Study: 34914294

Group type: EXPERIMENTAL
Intervention: Yishen Huoxue Decoction (1 dose a day, twice daily for 3 months)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Shengjing Tablets (4 tablets once, tid) combined with L-carnitine oral solution (10 ml, bid for 3 months)
Number of subjects: 60
Study: 36173691

Group type: EXPERIMENTAL
Intervention: Placebo analgesia
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control (no analgesia)
Number of subjects: 90
Study: 33221093

Group type: EXPERIMENTAL
Intervention: MBS width measurement
Number of subjects: 678

Group type: EXPERIMENTAL
Intervention: MBS height measurement
Number of subjects: 678

Group type: EXPERIMENTAL
Intervention: Comparison of bone width
Number of subjects: 678

Group type: EXPERIMENTAL
Intervention: Comparison of bone height
Number of subjects: 678
Study: 34740861

Group type: EXPERIMENTAL
Intervention: osimertinib
Number of subjects: 682

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 682
Study: 33662951

Group type: EXPERIMENTAL
Intervention: Individualized homeopathic medicines (IH) plus psychological counseling (PC)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo plus psychological counseling (PC)
Number of subjects: 62
Study: 32768154

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS with 3 mA and low dosage of flunarizine (2.5 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS with 3 mA and medium dosage of flunarizine (5 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS with 3 mA and high dosage of flunarizine (10 mg)
Number of subjects: 12
Study: 34836479

Group type: EXPERIMENTAL
Intervention: At-scale professional development program for math teachers lasting a full school year
Number of subjects: 341

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 341
Study: 34637849

Group type: EXPERIMENTAL
Intervention: Resistant fabric warming (RFW)
Number of subjects: 257

Group type: COMPARATOR
Intervention: Forced-air warming (FAW)
Number of subjects: 257
Study: 32539887

Group type: EXPERIMENTAL
Intervention: Parent modelling of fruit and vegetable intake
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Parent modelling of energy dense foods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Parent sedentary hours
Number of subjects: 0
Study: 35285017

Group type: EXPERIMENTAL
Intervention: Sleeping sound intervention (2 × 50-min face-to-face sessions plus follow-up phone call)
Number of subjects: 245

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Sleeping sound intervention
Number of subjects: 245
Study: 32273183

Group type: EXPERIMENTAL
Intervention: Relugolix
Number of subjects: 103

Group type: COMPARATOR
Intervention: Degarelix
Number of subjects: 103
Study: 35853297

Group type: EXPERIMENTAL
Intervention: Highest tertile of docosahexaenoic acid (DHA, 22:6n3)
Number of subjects: 2802

Group type: EXPERIMENTAL
Intervention: Alpha-linolenic acid (ALA, 18:3n3)
Number of subjects: 2802

Group type: EXPERIMENTAL
Intervention: Linoleic acid (LA, 18:2n6)
Number of subjects: 2802

Group type: EXPERIMENTAL
Intervention: Docosatetraenoic acid (DTA, 22:4n6)
Number of subjects: 2802
Study: 34187460

Group type: EXPERIMENTAL
Intervention: Guided self-study (G‐SS)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 51
Study: 34954406

Group type: EXPERIMENTAL
Intervention: Essential oil therapy
Number of subjects: 69

Group type: COMPARATOR
Intervention: Almond oil (placebo)
Number of subjects: 69
Study: 34967899

Group type: EXPERIMENTAL
Intervention: Bupivacaine liposome suspension block + oral placebo (BUP)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Lidocaine block + oral placebo (LID)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Lidocaine block + oral meloxicam (1 mg/kg) (LID + MEL)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Saline block + oral placebo (CON)
Number of subjects: 30
Study: 33004654

Group type: EXPERIMENTAL
Intervention: Ilioinguinal/Iliohypogastric nerve block (IINB) with 0.25% bupivacaine/epinephrine/clonidine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Transmuscular quadratus lumborum block (QLB) with 0.25% bupivacaine/epinephrine/clonidine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ilioinguinal/Iliohypogastric nerve block (IINB)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Transmuscular quadratus lumborum block (QLB)
Number of subjects: 60
Study: 35992984

Group type: EXPERIMENTAL
Intervention: Platelet Rich Plasma Injection (Group I)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Arthroscopy (Group II)
Number of subjects: 70
Study: 34228393

Group type: EXPERIMENTAL
Intervention: Oral‐B 3D White Luxe/Procter & Gamble (WL)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Listerine Advanced White/Johnson & Johnson (AW)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Colgate Max White/Colgate (MW)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: iWhite Whitening Mouthwash/Sylphar (iW)
Number of subjects: 40
Study: 32329986

Group type: EXPERIMENTAL
Intervention: Inhibitory transcranial magnetic stimulation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Excitatory transcranial magnetic stimulation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 20
Study: 36028807

Group type: EXPERIMENTAL
Intervention: Simulation training in addition to didactic teaching (n=53)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Didactic teaching alone (control group, n=52)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Simulation training for residents
Number of subjects: 105

Group type: COMPARATOR
Intervention: Didactic teaching alone for residents (control group)
Number of subjects: 105
Study: 35820993

Group type: EXPERIMENTAL
Intervention: .b (SBMT)
Number of subjects: 8376

Group type: COMPARATOR
Intervention: Standard social-emotional learning (TAU)
Number of subjects: 8376
Study: 33830175

Group type: EXPERIMENTAL
Intervention: Health Literacy (HL)
Number of subjects: 521
Study: 32498606

Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Behavioural intervention
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Combined intervention (tDCS + behavioural intervention)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control task
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 24
Study: 32071470

Group type: EXPERIMENTAL
Intervention: β‐TCP (easy‐graftTMCLASSIC)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (spontaneously healed)
Number of subjects: 15
Study: 32933348

Group type: EXPERIMENTAL
Intervention: Compassion-focused therapy (CFT) - 8 sessions
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 42
Study: 34045018

Group type: EXPERIMENTAL
Intervention: DASH diet
Number of subjects: 412

Group type: COMPARATOR
Intervention: Low sodium (50 mmol/day)
Number of subjects: 412

Group type: EXPERIMENTAL
Intervention: DASH diet combined with sodium reduction
Number of subjects: 412
Study: 36147143

Group type: EXPERIMENTAL
Intervention: Double J ureteral stent (Group A)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Percutaneous nephrostomy (Group B)
Number of subjects: 104
Study: 32266683

Group type: EXPERIMENTAL
Intervention: Digitally-mediated social stories
Number of subjects: 15

Group type: COMPARATOR
Intervention: Poem (attentional control)
Number of subjects: 15
Study: 34939179

Group type: EXPERIMENTAL
Intervention: 2% MeO-MBM
Number of subjects: 10

Group type: COMPARATOR
Intervention: 1% hydrocortisone
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 33356977

Group type: EXPERIMENTAL
Intervention: Awake Prone Positioning Strategy (APPS) plus usual care (UC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 40
Study: 32031254

Group type: EXPERIMENTAL
Intervention: Brief intervention designed to improve executive functions
Number of subjects: 175

Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 175
Study: 33359274

Group type: EXPERIMENTAL
Intervention: Continuous endurance training
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: High-intensity interval training
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Pyramid training
Number of subjects: 66
Study: 36156532

Group type: EXPERIMENTAL
Intervention: Prophylactic levetiracetam for 1 week
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Prophylactic levetiracetam for 6 weeks
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 81
Study: 33878858

Group type: EXPERIMENTAL
Intervention: Pulse-steroid treatment (250 mg/day methyl-prednisolone)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: High-dose steroid treatment (6 mg/day dexamethasone equivalent)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Standard-care therapy alone
Number of subjects: 150
Study: 35560234

Group type: EXPERIMENTAL
Intervention: Autologous RBC transfusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 0
Study: 33601316

Group type: EXPERIMENTAL
Intervention: Cervical cerclage retained for over 24 hours
Number of subjects: 68

Group type: COMPARATOR
Intervention: Cervical cerclage removed
Number of subjects: 68
Study: 33865379

Group type: EXPERIMENTAL
Intervention: Palliative Care in Day‐Hospital (PCDH)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional outpatient palliative care
Number of subjects: 0
Study: 34881512

Group type: EXPERIMENTAL
Intervention: 100% oxygen breathing
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Hypoxia (breathing a mixture of 88% nitrogen and 12% oxygen)
Number of subjects: 24
Study: 34437607

Group type: EXPERIMENTAL
Intervention: Usual physiotherapy care plus a wearables-based walking intervention (n = 12)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Usual physiotherapy care (control, n = 14)
Number of subjects: 26
Study: 32147425

Group type: EXPERIMENTAL
Intervention: High IAP (18‐22 mmHg) HIPEC
Number of subjects: 33

Group type: COMPARATOR
Intervention: Low IAP (8‐12 mmHg) HIPEC
Number of subjects: 33
Study: 34937600

Group type: EXPERIMENTAL
Intervention: Maternal exposure to the January 1998 Québec ice storm
Number of subjects: 147349

Group type: COMPARATOR
Intervention: Control group (unexposed mothers in unaffected regions)
Number of subjects: 147349
Study: 32169633

Group type: EXPERIMENTAL
Intervention: Novel video exposure
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (same video exposure)
Number of subjects: 80
Study: 32875492

Group type: EXPERIMENTAL
Intervention: Double VEGF/HGF gene therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 36428274

Group type: EXPERIMENTAL
Intervention: Mirror Therapy (MT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham Therapy (ST)
Number of subjects: 60
Study: 33063219

Group type: EXPERIMENTAL
Intervention: One-piece implant system (STM)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Two-piece implant system (BRA)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Contralateral teeth (control)
Number of subjects: 30
Study: 32266529

Group type: EXPERIMENTAL
Intervention: Cable tie ligation
Number of subjects: 67
Study: 36349758

Group type: EXPERIMENTAL
Intervention: S‐methyl‐L‐thiocitrulline (nNOS inhibitor)
Number of subjects: 12

Group type: COMPARATOR
Intervention: 0.9% saline (placebo control)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Phenylephrine (pressor control)
Number of subjects: 12
Study: 33789252

Group type: EXPERIMENTAL
Intervention: Reflexology intervention applied for 3 sessions a week for 12 weeks.
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group received no intervention, only routine treatment.
Number of subjects: 66
Study: 32326719

Group type: EXPERIMENTAL
Intervention: Risk factors for allergic rhinitis (AR)
Number of subjects: 5550

Group type: EXPERIMENTAL
Intervention: Daily outdoor time for more than 1 hour
Number of subjects: 5550

Group type: EXPERIMENTAL
Intervention: Breastfeeding for more than 6 months
Number of subjects: 5550
Study: 35814561

Group type: EXPERIMENTAL
Intervention: Xingnao kaiqiao acupuncture method combined with Temporal three needles
Number of subjects: 72

Group type: COMPARATOR
Intervention: Scalp acupuncture combined with body acupuncture
Number of subjects: 72
Study: 34588552

Group type: EXPERIMENTAL
Intervention: One USD incentive at months 0, 2, 5 and 6 (Dollar arm)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Routine care (Control group)
Number of subjects: 180
Study: 616081485

Group type: EXPERIMENTAL
Intervention: Bifocal LENTIS Comfort LS-313 MF15 lens (Oculentis, Germany)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard monofocal lens
Number of subjects: 20
Study: 33663460

Group type: EXPERIMENTAL
Intervention: Independent Consultation and Feedback System (ICFS) intervention program for 18 months alongside routine medical services
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine medical services
Number of subjects: 0
Study: 35465297

Group type: EXPERIMENTAL
Intervention: Intermittent docetaxel chemotherapy guided by circulating methylated glutathione S-transferase Pi-1 (mGSTP1)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Continue docetaxel 75 mg/m2 q3w in accordance with clinician’s usual practice
Number of subjects: 120
Study: 35022501

Group type: EXPERIMENTAL
Intervention: Gravid oviposition sticky (GOS) traps and dengue non-structural 1 (NS1) antigen test
Number of subjects: 8
Study: 33853721

Group type: EXPERIMENTAL
Intervention: realTMS group (high-frequency stimulation)
Number of subjects: 17

Group type: COMPARATOR
Intervention: shamTMS group (sham treatment)
Number of subjects: 17
Study: 35638904

Group type: EXPERIMENTAL
Intervention: WLE (Wide Local Excision)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Steroid therapy
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: WLE with total or partial duct excision
Number of subjects: 59
Study: 32445975

Group type: EXPERIMENTAL
Intervention: Wii training
Number of subjects: 32

Group type: COMPARATOR
Intervention: Non-Wii task-specific training (TST)
Number of subjects: 32
Study: 32391584

Group type: EXPERIMENTAL
Intervention: Anhydrous 0.454% w/w stannous fluoride/sodium fluoride toothpaste (Test)
Number of subjects: 185

Group type: COMPARATOR
Intervention: Sodium monofluorophosphate toothpaste (Negative control)
Number of subjects: 185

Group type: COMPARATOR
Intervention: Stannous chloride/sodium fluoride toothpaste (Positive control)
Number of subjects: 185
Study: 34545646

Group type: EXPERIMENTAL
Intervention: Emollient application with skincare advice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Skincare advice only (Control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Emollient application with moderate adherence
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Emollient application (Potentially related cutaneous eruptions)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Passive smoking exposure
Number of subjects: 0
Study: 32470421

Group type: EXPERIMENTAL
Intervention: Active therapeutic stimulation settings
Number of subjects: 160

Group type: COMPARATOR
Intervention: Subtherapeutic stimulation settings (Control)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Both groups (Active and Control)
Number of subjects: 160
Study: 35028668

Group type: EXPERIMENTAL
Intervention: Lenacapavir (up to 750 mg, single dose)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo (10 day monotherapy)
Number of subjects: 29
Study: 34323442

Group type: EXPERIMENTAL
Intervention: Quadratus lumborum block
Number of subjects: 346
Study: 32407810

Group type: EXPERIMENTAL
Intervention: Mifepristone-misoprostol
Number of subjects: 409

Group type: COMPARATOR
Intervention: Misoprostol-alone
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 409
Study: 36314219

Group type: EXPERIMENTAL
Intervention: Kangaroo mother care (KMC)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: KMC
Number of subjects: 28

Group type: COMPARATOR
Intervention: SC
Number of subjects: 28
Study: 34383296

Group type: EXPERIMENTAL
Intervention: Video feedback with two constructive 1-on-1 feedback sessions after the first and second video sessions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Video feedback with two constructive 1-on-1 feedback sessions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard feedback (control group)
Number of subjects: 0
Study: 33758121

Group type: EXPERIMENTAL
Intervention: Coronary revascularization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-invasive ischemia testing
Number of subjects: 0
Study: 32564489

Group type: EXPERIMENTAL
Intervention: BM-OT (Mother's Breast Milk Odor and Taste)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: BM-OT + HBs (Mother's Breast Milk Odor and Taste + Heartbeat Sounds)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: BM-OT + HBs + NNS (Mother's Breast Milk Odor and Taste + Heartbeat Sounds + Non-Nutritive Sucking)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Routine Care
Number of subjects: 138
Study: 34856958

Group type: EXPERIMENTAL
Intervention: Facility HIV self-testing (HIVST)
Number of subjects: 57
Study: 34344432

Group type: EXPERIMENTAL
Intervention: Facilitator-supported tailored online self-management programme (BOOST) for fatigue, pain, and faecal urgency/incontinence
Number of subjects: 680

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 680
Study: 32310130

Group type: EXPERIMENTAL
Intervention: Magnesium-based bioresorbable scaffolds (MgBRS)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 95
Study: 35676079

Group type: EXPERIMENTAL
Intervention: Arthroscopic partial meniscectomy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Physical therapy
Number of subjects: 100
Study: 32003303

Group type: EXPERIMENTAL
Intervention: Rumination
Number of subjects: 117

Group type: COMPARATOR
Intervention: Distraction
Number of subjects: 117
Study: 35179758

Group type: EXPERIMENTAL
Intervention: Energy-restricted diet (D group; n = 21)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Energy-restricted diet + Lactobacillus rhamnosus supplementation (DP group; n = 19)
Number of subjects: 40
Study: 33726843

Group type: EXPERIMENTAL
Intervention: Electronic prompt embedded in a Clinical Decision Support System (CDSS) for Screening, Brief intervention, and Referral to Treatment (SBIRT)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control arm (no access to CDSS)
Number of subjects: 23